Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency

v3.5.0.2
Stockholders' Deficiency
9 Months Ended
Sep. 30, 2016
Stockholders' Equity Note [Abstract]  
Stockholders' Deficiency
Note 10 – Stockholders’ Deficiency
 
Stock-Based Compensation
 
During the three and nine months ended September 30, 2016, the Company recognized $23,627 and $115,589, respectively, of stock-based compensation expense related to warrants. During the three and nine months ended September 30, 2015, the Company recognized $90,159 and $56,759, respectively, of stock-based compensation expense related to common stock and warrants. As of September 30, 2016, there was $68,661 of unrecognized stock-based compensation expense that will be recognized over approximately 0.7 years.